Combined Locoregional Treatment With Immunotherapy for Unresectable HCC.

Clinical trial NCT04220944 · UNKNOWN

Trial details

NCT number: NCT04220944
Sponsor: Shanghai Zhongshan Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Carcinoma

Start date: 2020-01-01
Primary completion: 2024-10-30
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.